CD23, a low-affinity IgE Fc receptor, is not displayed on most resting
T cells but its expression has been shown to be transiently induced i
n vivo and in vitro on some CD4(+) T cells [1-4] and in vivo on CD8(+)
T cells by IgE-secreting hybridoma tumors [5]. To investigate the fun
ctional role of CD23 on T cells, we inserted a CD23 construct into an
expression vector driven by a CD2 promoter and transfected it into a m
urine Th2 clone D10.G4.1 (D10). We stimulated the transfected D10 cell
s (D10.3M.24) with anti-TCR antibody in the presence or absence of IgE
, and measured IL-4, IL-5 and IL-6 production in the culture supernata
nts. Activation of D10.3M.24 cells by anti-TCR antibody induced greate
r levels of IL-4, IL-5 and IL-6 production, when the TCR and CD23 were
co-crosslinked by TNP anti-TCR and IgE anti-TNP antibodies. IgG anti-
TNP antibody did not enhance lymphokine production by D10.3M.24 cells.
The enhanced lymphokine production by IgE was blocked by monoclonal a
nti-CD23 antibody. IgE anti-TNP antibody did not enhance lymphokine pr
oduction by the wild-type D10 cells induced by TNP anti-TCR antibody.
These studies show that when co-crosslinked with the TCR, CD23 can mod
ulate the lymphokine production in activated Th2 cells. Since CD23 bin
ds to IgE and also binds to CD21 [6], a complement receptor commonly e
xpressed on B cells, T-cell CD23 could play an immunoregulatory role d
uring cognate T-B cell interaction and during IgE antibody responses.